Infinity Market Research
Infinity Market Research

Global Osteoporosis Biosimilars Market Growth 2025-2031


Sep 2025

Healthcare

Pages: 162

LPI8762

PDF Available
Word Available
Excel Available


The global Osteoporosis Biosimilars market size is predicted to grow from US$ 1890 million in 2025 to US$ 2341 million in 2031; it is expected to grow at a CAGR of 3.6% from 2025 to 2031.


Osteoporosis biosimilars are a class of follow-up biologic products that are equivalent to approved osteoporosis biologic drugs in quality, safety and efficacy. They go through a rigorous regulatory process and demonstrate no significant differences in key properties from the original drug, providing patients with additional treatment options and potentially increasing treatment accessibility due to their lower cost.


United States market for Osteoporosis Biosimilars is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.


China market for Osteoporosis Biosimilars is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.


Europe market for Osteoporosis Biosimilars is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.


Global key Osteoporosis Biosimilars players cover Biosidus SA, Cadila Pharmaceuticals, Gedeon Richter Australia Pty Ltd, Mochida Pharmaceutical Co., Ltd, STADA Arzneimittel AG, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.


Infinity Market Research newest research report, the ?Osteoporosis Biosimilars Industry Forecast? looks at past sales and reviews total world Osteoporosis Biosimilars sales in 2024, providing a comprehensive analysis by region and market sector of projected Osteoporosis Biosimilars sales for 2025 through 2031. With Osteoporosis Biosimilars sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Osteoporosis Biosimilars industry.


This Insight Report provides a comprehensive analysis of the global Osteoporosis Biosimilars landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Osteoporosis Biosimilars portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Osteoporosis Biosimilars market.


This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Osteoporosis Biosimilars and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Osteoporosis Biosimilars.


This report presents a comprehensive overview, market shares, and growth opportunities of Osteoporosis Biosimilars market by product type, application, key manufacturers and key regions and countries.


Segmentation by Type:


    250?g/mL
    60 mg/mL
    70 mg/mL


Segmentation by Application:


    Hospital
    Clinic
    Others


This report also splits the market by region:


    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries


The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration.


    Biosidus SA
    Cadila Pharmaceuticals
    Gedeon Richter Australia Pty Ltd
    Mochida Pharmaceutical Co., Ltd
    STADA Arzneimittel AG
    Alvogen, Inc
    Theramex Ireland Ltd
    Intas Pharmaceuticals Ltd
    Sun Pharma ANZ Pty Ltd
    Strides Pharma
    Apotex Corp
    Teva Pharmaceuticals, Inc
    Novartis AG
    Cipla Ltd
    CrownBio Science (Jilin) Co., Ltd
    LianKang Biotechnology Group
    Shanghai United Cell Bioengineering Co., Ltd
    Shenzhen Salubris Pharmaceuticals Co., Ltd
    Shandong Boyan Biotechnology Co., Ltd
    Mabwell (Shanghai) Biotechnology
    Qilu Pharmaceutical Co., Ltd


Key Questions Addressed in this Report


What is the 10-year outlook for the global Osteoporosis Biosimilars market?
What factors are driving Osteoporosis Biosimilars market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Osteoporosis Biosimilars market opportunities vary by end market size?
How does Osteoporosis Biosimilars break out by Type, by Application?

Osteoporosis Biosimilars Market Scope

Report AttributeDetails
Market Size (Start Year)USD XX Million
Market Size (End Year)USD XX Million
Compound Annual Growth Rate (CAGR)USD XX Million
Forecast PeriodUSD XX Million
Base YearUSD XX Million
Historical DataUSD XX Million
Key PlayersUSD XX Million

📘 Frequently Asked Questions

1. What is the market size of Global Osteoporosis Biosimilars Market?

Answer: The global Osteoporosis Biosimilars market size is predicted to grow from US$ 1890 million in 2025 to US$ 2341 million in 2031; it is expected to grow at a CAGR of 3.6% from 2025 to 2031.

2. Which regions are analyzed in the Global Osteoporosis Biosimilars Market report?

Answer: The Global Osteoporosis Biosimilars Market report covers major regions such as Europe, Middle East & Africa. Each region is analyzed for trends, opportunities, and market dynamics.

3. What methodology is used for forecasting of Global Osteoporosis Biosimilars Market?

Answer: The Global Osteoporosis Biosimilars Market report uses a mix of primary research, secondary data, and expert analysis to build its forecasts. Models include both qualitative and quantitative approaches.

4. Are emerging markets analyzed separately in the Global Osteoporosis Biosimilars Market?

Answer: Yes, the Global Osteoporosis Biosimilars Market report highlights high-growth emerging regions with dedicated insights. These include untapped opportunities, risks, and potential for expansion.

5. Does the report include competitive benchmarking of Global Osteoporosis Biosimilars Market?

Answer: Yes, Global Osteoporosis Biosimilars Market report compares major players based on revenue, product portfolio, innovation, and regional presence. This helps assess competitive positioning.

6. Can I access country-level data within the Global Osteoporosis Biosimilars Market report?

Answer: Yes, Global Osteoporosis Biosimilars Market report includes detailed data by country, especially for key markets. This allows for localized insights and decision-making.

7. Can I get customized insights or data from the Global Osteoporosis Biosimilars Market report?

Answer: Yes, we offer customization options to align with your specific business needs. You can request tailored sections or regional breakdowns.

🎁 This Month Only: Flat $1000 OFF

Enjoy an exclusive $1000 discount on every report purchased this month. No code needed.

Secure payment methods

🔐 Secure Payment Guaranteed

Safe checkout with trusted global payment methods.

🌟 Why Choose Infinity Market Research?

  • Accurate & Verified Data:Our insights are trusted by global brands and Fortune 500 companies.
  • Complete Transparency:No hidden fees, locked content, or misleading claims — ever.
  • 24/7 Analyst Support:Our expert team is always available to help you make smarter decisions.
  • Instant Savings:Enjoy a flat $1000 OFF on every report.
  • Fast & Reliable Delivery:Get your report delivered within 5 working days, guaranteed.
  • Tailored Insights:Customized research that fits your industry and specific goals.

📄 Available License Types

👤 Single User
$3660
$2660
👥 Multi User
$5490
$4490
🏢 Enterprise User
$7320
$6320
Buy Now
Secure payment methods

Recent Reports

Laboratory Degassers Market

Global Laboratory Degassers market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

Laboratory Funnel Market

Global Laboratory Funnel market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.